136 related articles for article (PubMed ID: 15292257)
1. Differential modulation of human melanoma cell metalloproteinase expression by alpha2beta1 integrin and CD44 triple-helical ligands derived from type IV collagen.
Baronas-Lowell D; Lauer-Fields JL; Borgia JA; Sferrazza GF; Al-Ghoul M; Minond D; Fields GB
J Biol Chem; 2004 Oct; 279(42):43503-13. PubMed ID: 15292257
[TBL] [Abstract][Full Text] [Related]
2. Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation.
Lauer-Fields JL; Malkar NB; Richet G; Drauz K; Fields GB
J Biol Chem; 2003 Apr; 278(16):14321-30. PubMed ID: 12574156
[TBL] [Abstract][Full Text] [Related]
3. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.
Knutson JR; Iida J; Fields GB; McCarthy JB
Mol Biol Cell; 1996 Mar; 7(3):383-96. PubMed ID: 8868467
[TBL] [Abstract][Full Text] [Related]
4. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion.
Lauer JL; Gendron CM; Fields GB
Biochemistry; 1998 Apr; 37(15):5279-87. PubMed ID: 9548759
[TBL] [Abstract][Full Text] [Related]
5. Modulation of triple-helical stability and subsequent melanoma cellular responses by single-site substitution of fluoroproline derivatives.
Malkar NB; Lauer-Fields JL; Borgia JA; Fields GB
Biochemistry; 2002 May; 41(19):6054-64. PubMed ID: 11994000
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation modulates melanoma cell α2β1 and α3β1 integrin interactions with type IV collagen.
Stawikowski MJ; Aukszi B; Stawikowska R; Cudic M; Fields GB
J Biol Chem; 2014 Aug; 289(31):21591-604. PubMed ID: 24958723
[TBL] [Abstract][Full Text] [Related]
7. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation.
Pasco S; Monboisse JC; Kieffer N
J Biol Chem; 2000 Oct; 275(42):32999-3007. PubMed ID: 10934203
[TBL] [Abstract][Full Text] [Related]
8. An all-D amino acid peptide model of alpha1(IV)531-543 from type IV collagen binds the alpha3beta1 integrin and mediates tumor cell adhesion, spreading, and motility.
Li C; McCarthy JB; Furcht LT; Fields GB
Biochemistry; 1997 Dec; 36(49):15404-10. PubMed ID: 9398270
[TBL] [Abstract][Full Text] [Related]
9. Mapping of potent and specific binding motifs, GLOGEN and GVOGEA, for integrin α1β1 using collagen toolkits II and III.
Hamaia SW; Pugh N; Raynal N; Némoz B; Stone R; Gullberg D; Bihan D; Farndale RW
J Biol Chem; 2012 Jul; 287(31):26019-28. PubMed ID: 22654115
[TBL] [Abstract][Full Text] [Related]
10. Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices.
Maaser K; Wolf K; Klein CE; Niggemann B; Zänker KS; Bröcker EB; Friedl P
Mol Biol Cell; 1999 Oct; 10(10):3067-79. PubMed ID: 10512851
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
12. Selective binding of integrins from different renal cell types to the NC1 domain of alpha3 and alpha1 chains of type IV collagen.
Aggeli AS; Kitsiou PV; Tzinia AK; Boutaud A; Hudson BG; Tsilibary EC
J Nephrol; 2009; 22(1):130-6. PubMed ID: 19229828
[TBL] [Abstract][Full Text] [Related]
13. The platelet reactivity of synthetic peptides based on the collagen III fragment alpha1(III)CB4. Evidence for an integrin alpha2beta1 recognition site involving residues 522-528 of the alpha1(III) collagen chain.
Morton LF; Peachey AR; Knight CG; Farndale RW; Barnes MJ
J Biol Chem; 1997 Apr; 272(17):11044-8. PubMed ID: 9110997
[TBL] [Abstract][Full Text] [Related]
14. Induction of endothelial cell activation by a triple helical alpha2beta integrin ligand, derived from type I collagen alpha1(I)496-507.
Baronas-Lowell D; Lauer-Fields JL; Fields GB
J Biol Chem; 2004 Jan; 279(2):952-62. PubMed ID: 14581484
[TBL] [Abstract][Full Text] [Related]
15. Promotion of cell adhesion by single-stranded and triple-helical peptide models of basement membrane collagen alpha 1(IV)531-543. Evidence for conformationally dependent and conformationally independent type IV collagen cell adhesion sites.
Miles AJ; Skubitz AP; Furcht LT; Fields GB
J Biol Chem; 1994 Dec; 269(49):30939-45. PubMed ID: 7983028
[TBL] [Abstract][Full Text] [Related]
16. Targeted drug delivery utilizing protein-like molecular architecture.
Rezler EM; Khan DR; Lauer-Fields J; Cudic M; Baronas-Lowell D; Fields GB
J Am Chem Soc; 2007 Apr; 129(16):4961-72. PubMed ID: 17397150
[TBL] [Abstract][Full Text] [Related]
17. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.
Faassen AE; Schrager JA; Klein DJ; Oegema TR; Couchman JR; McCarthy JB
J Cell Biol; 1992 Jan; 116(2):521-31. PubMed ID: 1730766
[TBL] [Abstract][Full Text] [Related]
18. Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for alpha1beta1 and alpha2beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen.
Loeser RF; Sadiev S; Tan L; Goldring MB
Osteoarthritis Cartilage; 2000 Mar; 8(2):96-105. PubMed ID: 10772239
[TBL] [Abstract][Full Text] [Related]
19. Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer.
Grzesiak JJ; Bouvet M
Pancreas; 2007 Mar; 34(2):220-8. PubMed ID: 17312461
[TBL] [Abstract][Full Text] [Related]
20. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells.
Pasco S; Han J; Gillery P; Bellon G; Maquart FX; Borel JP; Kefalides NA; Monboisse JC
Cancer Res; 2000 Jan; 60(2):467-73. PubMed ID: 10667602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
